Work

New Small-Molecule Synthetic Antimycobacterials

Year: 2005

Type: review

Abstract: Drugs for treating tuberculosis (TB) have been available for over half a century, and yet the incidence of disease worldwide continues to rise year by year. In 2002, the last year for which statistics are available, it is estimated that 24,000 people developed active disease and close to 5,000

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.49.6.2153-2163.2005

Authors: Lluis Ballell, Robert A. Field, Ken Duncan, Robert J. Young

Institutions: University of East Anglia, GlaxoSmithKline (United Kingdom)

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, Wellcome Trust, U.S. Food and Drug Administration, Biotechnology and Biological Sciences Research Council